Surgalign Holdings, Inc. to Participate at the 23rd Annual ICR/Westwicke Conference
Deerfield, Ill., January 11, 2021 – Surgalign Holdings, Inc. (Nasdaq: SRGA), a global pure-play spine company focused on advancing spine surgery including through the application of digital technologies to improve patient outcomes, today announced that the management team will participate in the 23rd Annual ICR/Westwicke Conference on Thursday, January 14, 2021.
The Company is scheduled to present at 2:30 p.m. ET on January 14, 2021
Panel Discussion: Digital Surgery
Dr. Simineov, the Company’s Chief Medical Officer, will participate in a panel discussion at 10:00am ET on January 14, 2021 on the topic of digital surgery.
A live webcast of the conference presentation and panel will be available online through the investor relations page of the Company’s website at surgalign.com/investors/. A replay of the webcast will be archived on the website for approximately 90 days.
About Surgalign Holdings, Inc.
Surgalign Holdings, Inc. is a global medical technology company advancing the science of spine care, focused on delivering innovative solutions that drive superior clinical and economic outcomes. The company is building off a legacy of high quality and differentiated products, and continues to invest in clinically validated innovation to deliver better surgical outcomes and improve patient’s lives. Surgalign markets products throughout the United States and in more than 50 countries worldwide through an expanding network of top independent distributors. Surgalign, a member of AdvaMed, is headquartered in Deerfield, IL, with commercial, innovation and design centers in San Diego, CA, Marquette, MI, and Wurmlingen, Germany. Learn more at www.surgalign.com and connect on LinkedIn and Twitter.
Forward Looking Statement
This communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s current expectations, estimates and projections about our industry, our management’s beliefs and certain assumptions made by our management. Words such as “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and are subject to risks and uncertainties, including the risks described in public filings with the U.S. Securities and Exchange Commission (SEC). Our actual results may differ materially from the anticipated results reflected in these forward-looking statements. Copies of the company’s SEC filings may be obtained by contacting the company or the SEC or by visiting Surgalign’s website at www.surgalign.com or the SEC’s website at www.sec.gov.
Investor and Media Contact
+1 224 303 4651